From the Editors

TOP - February 2016, Vol 9, No 1 - From the Editors
Patrick J. Medina, PharmD, BCOP
Professor of Clinical and Administrative Sciences
University of Oklahoma College of Pharmacy
Tulsa, OK
Steve Stricker, PharmD, MS, BCOP

In the February issue of The Oncology Pharmacist, we feature a recent study that was presented at the 2015 Palliative Care in Oncology Symposium on aprepitant (Emend), a centrally acting neurokinin-1 antagonist indicated for patients with chemotherapy-induced nausea and vomiting. The study authors found that aprepitant led to a reduction in cough frequency and improvement in the objective and subjective measures of cough in patients with lung cancer. We also highlight notable studies that were presented at the 57th American Society of Hematology Annual Meeting & Exposition, the American Society for Radiation Oncology 2015 Annual Meeting, and the San Antonio Breast Cancer Symposium.

In addition to conference news, we provide valuable insight on how the Affordable Care Act may affect drug pricing, US Food and Drug Administration news updates, using life insurance as a charitable vehicle, and treating patients with myelofibrosis.

In this issue's reader poll, we ask you whether certain treatments are beneficial for postmenopausal women with ductal carcinoma in situ. Please visit our website, www.TheOncologyPharmacist.com, and let us know whether this is what you have observed in your everyday practice. You can also send comments to info@TheOncologyPharmacist.com. We hope you will enjoy this issue, and look forward to your feedback.

Related Items
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - November 2017, Vol 10, No 6 published on November 27, 2017 in From the Editors
From The Editors - TOP November 2017
TOP - November 2017, Vol 10, No 4 published on November 13, 2017 in From the Editors
From the Editors
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - July 2017, Vol 10, No 4 published on July 6, 2017 in From the Editors
From the Editor
TON - May 2017, Vol 10, No 3 published on May 17, 2017 in From the Editors
From the Editors
Patrick J. Medina, PharmD, BCOP, Steve Stricker, PharmD, MS, BCOP
TOP - May 2017, Vol 10, No 2 published on May 5, 2017 in From the Editors
From The Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - March 2017, Vol 10, No 2 published on March 7, 2017 in From the Editors
From the Editors
Patrick J. Medina, PharmD, BCOP, Steve Stricker, PharmD, MS, BCOP
TOP - February 2017, Vol 10, No 1 published on February 1, 2017 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - January 2017, Vol 10, No 1 published on January 12, 2017 in From the Editors
New and Emerging Developments in the Management of Chronic Lymphocytic Leukemia: Role of the Pharmacist
Patrick J. Medina, PharmD, BCOP
JHOP - December 2016 Vol 6, No 4 published on December 2, 2016 in Editorial
Last modified: March 31, 2016